DURGA MAINALY: Open Payments
NPI 1356049753 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 85 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $428 · 2025 $1,506
Food & beverage: $1,506
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $253 |
| UCB, Inc. | 14 | $227 |
| Neurocrine BioSciences, Inc. | 13 | $165 |
| Teva Pharmaceuticals USA, Inc. | 7 | $147 |
| JAZZ PHARMACEUTICALS INC. | 4 | $116 |
| Eisai Inc. | 4 | $84 |
| ACADIA Pharmaceuticals Inc | 3 | $76 |
| Biogen, Inc. | 3 | $66 |
| Neurelis, Inc. | 2 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
Products named: INGREZZA, AUSTEDO XR, Leqembi, Rystiggo, QULIPTA, NUPLAZID, EPIDIOLEX, VYALEV.
Industry payments across TX — which companies pay providers there.
